Angelo Dei Tos

Angelo Paolo Dei Tos , Vanna Chiarion-Sileni , Stella Blandamura , Rocco Cappellesso
Journal of Experimental & Clinical Cancer Research 40 ( 1) 154 -154

2021

Lymph node core needle biopsy in lymphoproliferative disorders-Authors' reply to Al-Abbadi and colleagues.

Angelo Paolo Dei Tos , Pier Luigi Zinzani , Claudio Agostinelli , Marta Sbaraglia
European Journal of Haematology

2021

The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Pina Ziranu , Eleonora Lai , Marta Schirripa , Marco Puzzoni
Targeted Oncology 1 -11

2021

Clinical, Histological, and Molecular Features of Solitary Fibrous Tumor of Bone: A Single Institution Retrospective Review.

Angelo Paolo Dei Tos , Katia Scotlandi , Marco Gambarotti , Elena Pedrini
Cancers 13 ( 10) 2470

2021

mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs.

Chiara Borga , Carlo Alberto Dal Pozzo , Elisabetta Trevellin , Francesca Bergamo
Endocrine-related Cancer -1

2021

Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology

Angelo Paolo Dei Tos , Federica Lovisa , Vincenza Guzzardo , Lara Mussolin
Frontiers in Oncology 11

2021

Alpha, Beta, and Gamma HPV Infection in Juvenile Onset Recurrent Respiratory Papillomatosis

Angelo Paolo Dei Tos , Sandrine McKay-Chopin , Marta Sbaraglia , Marianna Sari

2021

Impact of pathological stratification of advanced well differentiated/dedifferentiated (WD/DD) liposarcoma (LPS) on the response to trabectedin (T).

Rossella Bertulli , Salvatore Provenzano , Carlo Morosi , Alessandro Gronchi
Journal of Clinical Oncology 36 11566 -11566

2018

Characterization of tumor microenvironment in extraskeletal myxoid chondrosarcoma (EMC).

Valentina Indio , Annalisa Astolfi , Giuseppe Tarantino , Milena Urbini
Journal of Clinical Oncology 36 11561 -11561

2018

Bruno Vincenzi , Salvatore Provenzano , Antonella Brunello , Giuseppe Badalamenti
Journal of Clinical Oncology 36 11556 -11556

2018

Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant + 2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.

Silvia Stacchiotti , Sara Pizzamiglio , Antonella Messina , Carlo Morosi
Journal of Clinical Oncology 36 11558 -11558

2018

Doxorubicin (D), gemcitabine (G), ifosfamide (I) and the EZH2 inhibitor EPZ-011989 in epithelioid sarcoma (ES): A comparison of different regimens in a patient-derived xenograft (PDX) model.

Nadia Zaffaroni , Anna Maria Frezza , Valentina Zuco , Alessandro Gronchi
Journal of Clinical Oncology 36 11578 -11578

2018

Benign metastasizing leiomyoma (BML): A retrospective case series analysis of 8 patients (pts).

Vittoria Colia , Angelo Paolo Dei Tos , Elena Fumagalli , Rossella Bertulli
Journal of Clinical Oncology 35

2017

Desmoid-type fibromatosis: from morphology to molecular genetics

Sabrina Rossi , Licia Laurino , Angelo Paolo Dei Tos
Diagnostic Histopathology 14 ( 11) 546 -551

2008

Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary

Paolo Boscolo‐Rizzo , Lea Schroeder , Valeria Sacchetto , Dana Holzinger
Head and Neck-journal for The Sciences and Specialties of The Head and Neck 41 ( 11) 3833 -3841

2019

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

Bruno Vincenzi , Margherita Nannini , Elena Fumagalli , Giuseppe Bronte
Oncotarget 7 ( 43) 69412 -69419

2016

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Lionel Perrier , Alessandra Buja , Giuseppe Mastrangelo , Antonella Vecchiato
BMC Health Services Research 12 ( 1) 82 -82

2012